Sign in
4

Changes in Ownership

Adaptive Biotechnologies Corp Filed Acc 0001209191-21-065839

Chief Scientific Officer sold 4,000 shares at an average $32.00 ($127,993)

  • Chief Scientific Officer acquired 4,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

ROBINS HARLAN S · Chief Scientific Officer

Table I: Non-derivative

4 lines
Date Transaction Shares Price Value Owned after D/I
2021-11-17 Exercise or conversion : show line 1 in the form +3,700 $6.55 $24,235 73,060 D
2021-11-17 Sale : show line 2 in the form −3,700 $32.05 $118,585 69,360 D
2021-11-18 Exercise or conversion : show line 3 in the form +300 $6.55 $1,965 69,660 D
2021-11-18 Sale : show line 4 in the form −300 $31.36 $9,408 69,360 D
Open-market sales · 4,000 sh · avg $32.00 · $127,993

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2021-11-17 Exercise or conversion : show line 5 in the form Stock Option (Right to Buy) −3,700 285,100 D
2021-11-18 Exercise or conversion : show line 6 in the form Stock Option (Right to Buy) −300 284,800 D
Loading xslF345X03/doc4.xml…